Page 307 - ATP-P 11th Ed

° Before using chloroquine for prophylaxis, it should be ascertained whether chloro-
quine is appropriate for use in the region to be visited by the traveler. Chloroquine
should not be used for treatment of P. falciparum infections acquired in areas of chlo-
roquine resistance or malaria occurring in patients where chloroquine prophylaxis
has failed. Patients infected with a resistant strain of plasmodia, as shown by the fact
that normally adequate doses have failed to prevent or cure clinical malaria or para-
sitemia, should be treated with another form of antimalarial therapy.
Drug interactions:
• Ampicillin
• Antacids
• Cimetidine
• Cyclosporine
• Kaolin
• Magnesium trisilicate
TMEP use: Malaria Protocol
®
Cialis – See Tadalafil SECTION 3
®
Cyklokapron – See Tranexamic Acid (TXA)
®
Combivir (Lamivudine and Zidovudine [AZT, ZDV])
GROUNDING medication for personnel on flight status
Indications: HIV infection
Dose: One Combivir tablet given twice daily
®
Contraindications: Known allergy to medication
Pregnancy Category C
Side-effects:
• Cardiovascular:
° Cardiomyopathy
• Endocrine and metabolic:
° Gynecomastia
° Hyperglycemia
• Gastrointestinal:
° Oral mucosal pigmentation
° Stomatitis
° Nausea
° Vomiting
° Diarrhea
° Decreased appetite
• General:
° Vasculitis
ATP-P Handbook 11th Edition 297